Pau Bosch‐Nicolau

Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

Belén Gutiérrez‐Gutiérrez, Alberto M. Borobia, Antonio J. Carcas et al. · The Lancet Infectious Diseases · 2021 · 102 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +13

Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II superiority clinical trial

Daniel Molina‐Morant, Marisa Fernández, Pau Bosch‐Nicolau et al. · Trials · 2020 · 62 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression

Pau Bosch‐Nicolau, María Ubals, Fernando Salvador et al. · PLoS neglected tropical diseases · 2019 · 51 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +17

Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ): an international, randomised, double-blind, phase 2b trial

Pau Bosch‐Nicolau, Marisa Fernández, Elena Sulleiro et al. · The Lancet Infectious Diseases · 2024 · 42 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +5

Human papillomavirus and breast cancer: no evidence of association in a Spanish set of cases.

M. Vernet-Tomás, M. Mena, Laia Alemany et al. · PubMed · 2015 · 38 citations · Full text

Medicine, Oncology, Pathology +15